You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
名臣健康(002919.SZ):5名股東減持期屆滿 擬繼續減持不超262.2萬股
格隆匯 09-08 16:50

格隆匯 9 月 8日丨名臣健康(002919.SZ)公佈,近日,公司收到股東許紹壁、彭小青、林典希、餘建平、陳東鬆出具的《關於股份減持計劃期限屆滿的告知函》。鑑於此次減持計劃期限已經屆滿,截至公告日,此次減持計劃期限已經屆滿;公司股東許紹壁、彭小青、林典希、陳東鬆未通過任何方式減持公司股份;公司股東餘建平通過集中競價方式減持20.0萬股,佔總股本比例0.1638%。

公司於近日收到公司董事許紹壁,公司董事、高管彭小青、林典希及公司高管餘建平、陳東鬆出具的《股份減持計劃告知函》。

截至減持計劃公告之日,許紹壁持有公司股份520萬股,佔公司總股本比例4.26%;彭小青持有公司股份162.75萬股,佔公司總股本比例1.33%;林典希持有公司股份161.75萬股,佔公司總股本比例1.32%;餘建平持有公司股份145.25萬股,佔公司總股本比例1.19%;陳東鬆持有公司股份129.15萬股,佔公司總股本比例1.06%。

許紹壁預計所減持股份數量將不超過128萬股,即不超過公司現時總股本的1.05%;彭小青預計所減持股份數量將不超過40.6萬股,即不超過公司現時總股本的0.33%;林典希預計所減持股份數量將不超過40.4萬股,即不超過公司現時總股本的0.33%;餘建平預計所減持股份數量將不超過21萬股,即不超過公司現時總股本的0.17%;陳東鬆預計所減持股份數量將不超過32.2萬股,即不超過公司現時總股本的0.26%。

以上減持公司股份合計不超過262.2萬股(佔公司總股本比例為2.15%)。若通過證券交易所集中競價交易方式進行減持的,將於本減持計劃公告之日起15個交易日後的六個月內進行。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account